108 related articles for article (PubMed ID: 8065012)
1. Risk factors for carotid atherosclerosis and platelet activation.
Uyama O; Matsui Y; Shimizu S; Michishita H; Sugita M
Jpn Circ J; 1994 Jun; 58(6):409-15. PubMed ID: 8065012
[TBL] [Abstract][Full Text] [Related]
2. Urinary 11-dehydro-thromboxane B2: a quantitative index of platelet activation in cerebral infarction.
Uyama O; Shimizu S; Nakanishi T; Nakahama H; Takiguchi A; Hayashi Y; Yamamoto S; Sugita M
Intern Med; 1992 Jun; 31(6):735-9. PubMed ID: 1392173
[TBL] [Abstract][Full Text] [Related]
3. Vasoactive and atherogenic effects of cigarette smoking: a study of monozygotic twins discordant for smoking.
Lassila R; Seyberth HW; Haapanen A; Schweer H; Koskenvuo M; Laustiola KE
BMJ; 1988 Oct; 297(6654):955-7. PubMed ID: 3142565
[TBL] [Abstract][Full Text] [Related]
4. Smoking alters thromboxane metabolism in man.
Uedelhoven WM; Rützel A; Meese CO; Weber PC
Biochim Biophys Acta; 1991 Jan; 1081(2):197-201. PubMed ID: 1998738
[TBL] [Abstract][Full Text] [Related]
5. Significance of urinary 11-dehydro-thromboxane B
Simeone P; Boccatonda A; Liani R; Santilli F
Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
[TBL] [Abstract][Full Text] [Related]
6. Cigarette smoking is associated with increased circulating proinflammatory and procoagulant markers in patients with chronic coronary artery disease: effects of aspirin treatment.
Ikonomidis I; Lekakis J; Vamvakou G; Andreotti F; Nihoyannopoulos P
Am Heart J; 2005 May; 149(5):832-9. PubMed ID: 15894964
[TBL] [Abstract][Full Text] [Related]
7. Paired analysis of urinary thromboxane B2 metabolites in humans.
Catella F; FitzGerald GA
Thromb Res; 1987 Sep; 47(6):647-56. PubMed ID: 3686481
[TBL] [Abstract][Full Text] [Related]
8. Correlations between peripheral differential leukocyte counts and carotid atherosclerosis in non-smokers.
Huang ZS; Jeng JS; Wang CH; Yip PK; Wu TH; Lee TK
Atherosclerosis; 2001 Oct; 158(2):431-6. PubMed ID: 11583723
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay.
Riutta A; Mucha I; Vapaatalo H
Anal Biochem; 1992 May; 202(2):299-305. PubMed ID: 1519756
[TBL] [Abstract][Full Text] [Related]
10. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
Dharmasaroja PA; Sae-Lim S
J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
[TBL] [Abstract][Full Text] [Related]
11. In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis.
Knapp HR; Reilly IA; Alessandrini P; FitzGerald GA
N Engl J Med; 1986 Apr; 314(15):937-42. PubMed ID: 3007982
[TBL] [Abstract][Full Text] [Related]
12. Aspirin, but not heparin, suppresses the transient increase in thromboxane biosynthesis associated with cardiac catheterization or coronary angioplasty.
Ciabattoni G; Ujang S; Sritara P; Andreotti F; Davies G; Simonetti BM; Patrono C; Maseri A
J Am Coll Cardiol; 1993 May; 21(6):1377-81. PubMed ID: 8473644
[TBL] [Abstract][Full Text] [Related]
13. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease.
Davì G; Gresele P; Violi F; Basili S; Catalano M; Giammarresi C; Volpato R; Nenci GG; Ciabattoni G; Patrono C
Circulation; 1997 Jul; 96(1):69-75. PubMed ID: 9236419
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females.
Dotevall A; Rångemark C; Eriksson E; Kutti J; Wadenvik H; Wennmalm A
Thromb Haemost; 1992 Nov; 68(5):583-8. PubMed ID: 1455405
[TBL] [Abstract][Full Text] [Related]
16. Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events.
Thomson VS; John B; George P; Joseph G; Jose J
J Postgrad Med; 2009; 55(4):252-6. PubMed ID: 20083870
[TBL] [Abstract][Full Text] [Related]
17. Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis?
Varnell CD; Goldstein SL; Yee DL; Teruya J; Guyer KE; Siddiqui S; Jefferies JL
Pediatr Blood Cancer; 2014 Nov; 61(11):2074-6. PubMed ID: 24803308
[TBL] [Abstract][Full Text] [Related]
18. Tandem mass spectrometric determination of 11-dehydrothromboxane B2, an index metabolite of thromboxane B2 in plasma and urine.
Schweer H; Meese CO; Fürst O; Kühl PG; Seyberth HW
Anal Biochem; 1987 Jul; 164(1):156-63. PubMed ID: 3674365
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
Ciabattoni G; Maclouf J; Catella F; FitzGerald GA; Patrono C
Biochim Biophys Acta; 1987 Apr; 918(3):293-7. PubMed ID: 3567215
[TBL] [Abstract][Full Text] [Related]
20. Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs.
Rautanen M; Gullichsen E; Riutta A; Kuttila K; Mucha I; Nelimarkka O; Niinikoski J
Crit Care Med; 1997 Jul; 25(7):1215-21. PubMed ID: 9233750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
